Abstract:The medical and surgical treatment of endometrial cancer (EC) is evolving toward a more patient-centered and personalized approach. The role of laparoscopic sentinel node biopsy (SNB) for early-stage EC is unclear, and very few data are available for atypical endometrial hyperplasia (AEH). The present study investigated the effectiveness of SNB combined with laparoscopic hysterectomy in patients with early-stage EC and AEH. This was a retrospective, single-center cohort study for the period from January 2018 to December 2023. A total of 102 patients with atypical hyperplasia (n = 20) and early-stage EC (n = 82) findings on diagnostic curettage underwent pelvic sentinel node biopsy during the final operation. Eleven patients (55%) who had initially been diagnosed with AEH were found to have EC in the final pathology report. No lymph node metastases were detected in patients who had initially been diagnosed with AEH; a 3.6% rate of positive SNBs was found in patients with EC. Changes in tumor grade occurred in 31.3% of the patients and changes in FIGO stage in 33%. Bilateral sentinel node (SN) mapping was successful in 94.1% of the patients. The postoperative outcomes were comparable to those of routine clinical practice without SNB. SNB can be safely offered to patients who have precursor lesions and early-stage EC without notably extending surgical times or increasing postoperative morbidity. This approach can be considered and is safe for patients diagnosed with AEH, but it appears to have a rather small impact on these patients. Die medizinisch-chirurgische Behandlung des Endometriumkarzinoms (EK) verändert sich hin zu einer mehr patientenorientierten und personalisierten Vorgehensweise. Die Rolle der laparoskopisch durchgeführten Sentinel-Lymphknoten-Biopsie (SNB) bei EK im Frühstadium ist noch unklar, und es gibt nur wenige Daten zur atypischen Endometriumhyperplasie (AEH). Die vorliegende Studie untersuchte die Effektivität von SNB in Kombination mit einer laparoskopischen Hysterektomie bei Patientinnen mit EK im Frühstadium und AEH. Es handelt sich um eine retrospektive monozentrische Kohortenstudie, die zwischen Januar 2018 bis Dezember 2023 durchgeführt wurde. Insgesamt erhielten 102 Patientinnen mit dem Befund der atypischen Hyperplasie (n = 20) und EK im Frühstadium (n = 82) nach diagnostischer Abrasio während der endgültigen Operation eine Sentinel-Lymphknoten-Biopsie. Bei 11 Patientinnen (55%), die ursprünglich mit AEH diagnostiziert wurden, wurde gemäß dem abschließenden Pathologiebericht ein EK identifiziert. Es wurden keine Lymphknotenmetastasen bei Patientinnen gefunden, deren ursprüngliche Diagnose AEH lautete; die Rate der positiven SNB bei Patientinnen mit EK betrug 3,6%. Bei 31,3% der Patientinnen kam es zu einer Veränderung des Tumorgrads und bei 33% zu einer Änderung des FIGO-Stadiums. Das bilaterale Sentinel-Lymphknoten-Mapping war bei 94,1% der Patientinnen erfolgreich. Die postoperativen Ergebnisse aller Patientinnen waren mit denen eines routinemäßigen chirurgischen Eingriffs ohne Durchführung einer SNB vergleichbar. Die SNB kann problemlos bei Patientinnen mit Vorläuferläsionen und EK im Frühstadium durchgeführt werden, ohne dass sich die Operationszeit wesentlich verlängert oder sich die postoperative Morbidität erhöht. Während diese Vorgehensweise für Patientinnen mit einer Diagnose von AEH als sicher betrachtet werden kann und ist, scheint sie nur geringe Auswirkungen auf diese Patientinnen zu haben. Received: 29 January 2024 Accepted after revision: 20 March 2024 Article published online: 29 May 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Clinical and Surgical Evaluation of Sentinel Node Biopsy in Patients with Early-Stage Endometrial Cancer and Atypical Hyperplasia

Should we prioritise proper surgical staging for patients with Atypical endometrial hyperplasia (AEH)? Experience from a single-institution tertiary care oncology centre

Laparoscopic sentinel lymph node detection after hysteroscopic injection of technetium-99 in patients with endometrial cancer

Role of sentinel lymph node evaluation during hysterectomy for preoperative pathology diagnosis of endometrial intraepithelial neoplasia in a community hospital setting

Sentinel lymph node biopsy at robotic-assisted hysterectomy for atypical hyperplasia and endometrial cancer

Sentinel lymph node biopsy in endometrial cancer: When, how and in which patients

Atypical Endometrial Hyperplasia and Concurrent Cancer: A Comprehensive Overview on a Challenging Clinical Condition

Sentinel Lymph Node Biopsy Versus Pelvic Lymphadenectomy In Early-Stage Cervical Cancer: A Multi-Center Randomized Trial (Phenix/Csem 010)

Evaluation of Different Risk Factors for Metastatic Sentinel Lymph Nodes in Endometrial Cancer

Accuracy and Survival Outcomes after National Implementation of Sentinel Lymph Node Biopsy in Early Stage Endometrial Cancer

The Evaluation of Sentinel Lymph Node Biopsy Using Radiocolloid in First Stage Endometrial Cancer

Prevalence and size of pelvic sentinel lymph node metastases in endometrial cancer

Pre-operative surgical algorithm: sentinel lymph node biopsy as predictor of parametrial involvement in early-stage cervical cancer

The SENTIREC-endo study - Risks and benefits of a national adoption of sentinel node mapping in low and intermediate risk endometrial cancer

Accuracy of robotic sentinel lymph node detection (RSLND) for patients with endometrial cancer (EC)

A retrospective validation study of sentinel lymph node mapping for high-risk endometrial cancer

750 Diagnostic Accuracy of Sentinel Node Biopsy in Non-Endometrioid, High-Grade And/or Deep Myoinvasive Endometrial Cancer (TRSGO-SLN-006)

Is fluorometric sentinel lymph node biopsy in endometrial cancer necessary?

Predictive Score of Nodal Involvement in Endometrial Cancer Patients: A Large Multicentre Series

Concurrent Endometrial Cancer in Women with Atypical Endometrial Hyperplasia: What Is the Predictive Value of Patient Characteristics?

Endometrial Cancer Lymphadenectomy Trial (ECLAT) (pelvic and para-aortic lymphadenectomy in patients with stage I or II endometrial cancer with high risk of recurrence; AGO-OP.6)